Actively Recruiting
Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).
Led by University of Guadalajara · Updated on 2026-03-23
26
Participants Needed
2
Research Sites
30 weeks
Total Duration
On this page
Sponsors
U
University of Guadalajara
Lead Sponsor
H
Hospital Civil de Guadalajara
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this clinical trial is to evaluate whether a nutritional supplement containing resveratrol, quercetin, taurine, inulin, and whey protein improves biochemical and molecular markers, as well as clinical outcomes, in patients with liver disease related to chronic hepatitis C infection. The study will compare the investigational supplement with an active control (whey protein alone) to determine whether the combination formulation provides additional benefits on liver-related biomarkers and clinical assessment. Participants will: Take the investigational supplement or active control daily for 12 weeks. Attend clinic visits every 4 weeks for laboratory testing and clinical evaluations.
CONDITIONS
Official Title
Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with liver disease secondary to chronic hepatitis C virus infection attending the outpatient Hepatitis Clinic at Hospital Civil Fray Antonio Alcalde
- Child-Pugh score less than 8 points
- Age between 18 and 69 years
- Both sexes
- Signed informed consent
You will not qualify if you...
- Alcohol consumption within the past 6 months
- History of acute-on-chronic liver failure (ACLF)
- Persistent hepatic encephalopathy
- Unable to perform frailty assessments
- Refractory ascites
- History of hepatorenal syndrome
- History of hepatopulmonary syndrome
- Chronic kidney disease
- Autoimmune diseases
- Any type of cancer
- Dementia or other significant mental illnesses
- Use of protein supplements or probiotics
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Hospital Civil de Guadalajara Fray Antonio Alcalde
Guadalajara, Jalisco, Mexico, 44280
Actively Recruiting
2
Hospital Civil de Guadalajara Fray Antonio Alcalde
Guadalajara, Jalisco, Mexico
Actively Recruiting
Research Team
J
Juan Roberto Rodriguez-Echevarria, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here